š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
To evaluate the safety and efficacy of the Absorb BVS System compared to th...
Status
Completed
Location
Abbott Vascular
Start Date
2013-07
Trial ID
NCT01923740
Treatments Being Tested
The target enrollment goal for the trial was to enroll 36 subjects. However...
Status
Terminated
Location
Austin Health
Start Date
2011-11
Trial ID
NCT01308346
Prospective, randomized (2:1), active control, single blinded, parallel two...
Status
Completed
Location
Abbott Vascular International BVBA
Start Date
2011-11
Trial ID
NCT01425281
This is a Prospective, randomized (1:1), active control, single-blind, non-...
Status
Completed
Location
Research centre Aarhus, DK003
Start Date
2014-01-06
Trial ID
NCT01986803
Treatments Being Tested
To evaluate the efficacy and performance in an all-comers contemporary popu...
Status
Unknown
Location
AMC
Start Date
2013-08
Trial ID
NCT01858077
Treatments Being Tested
The purpose of this study is to assess the safety and performance of the BV...
Status
Completed
Location
St. Vincent's Hospital
Start Date
2009-03
Trial ID
NCT00856856
Treatments Being Tested
Prospective, open-labeled First in Man Clinical Investigation enrolling pat...
Status
Completed
Location
Skejby Sygehus
Start Date
2006-03
Trial ID
NCT00300131
Treatments Being Tested
The purpose of the Surveillance is to know the frequency and status of adve...
Status
Completed
Location
Nagoya Daini Red Cross Hospital
Start Date
2016-12-13
Trial ID
NCT03409731
Treatments Being Tested
The primary objective of this study is to demonstrate superiority of the Ab...
Status
Unknown
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT03529006
Treatments Being Tested
ABSORB IV is a prospective, randomized (1:1, Absorb BVS to XIENCE), single-...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-07
Trial ID
NCT02173379
Treatments Being Tested